GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

People living with type 2 diabetes face several significant health challenges. The condition, which affects more than 10% of ...

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

Most of us know someone that has been affected by diabetes. It can lead to severe health problems, such as eye problems, ...

Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Drugs to treat gastrointestinal and cardiovascular diseases, painkillers and anti-diabetic medicines recorded the maximum ...

A new study found that over 800 million adults have diabetes worldwide — almost twice as many as previous estimates have ...